Enhancing m6A modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer
Authors:
- Bixia LiuBLBixia Liu
Open Access
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2019M653194)
- National Natural Science Foundation of China (82073047)
- National Natural Science Foundation of China (82272995)
This publication has 37 references indexed in Scilit:
- Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancerAging, 2020
- HOTAIR LncRNA: A novel oncogenic propellant in human cancerClinica Chimica Acta, 2020
- lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signalingMolecular Cancer, 2020
- N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancerEBioMedicine, 2019
- METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent mannerMolecular Cancer, 2019
- The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling networkOncogene, 2019
- Canadian Urological Association guideline: Muscle-invasive bladder cancerCanadian Urological Association Journal, 2018
- Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancerMolecular Cancer, 2018
- Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer SubtypesFrontiers in Genetics, 2018
- m6A RNA methylation promotes XIST-mediated transcriptional repressionNature, 2016